MS Stem Cell Trial: What the Results Mean for Patients
Key Takeaways A new randomized trial tested injecting mesenchymal stem cells into the spinal fluid of 18 people with progressive MS. The trial’s main measure of nerve repair did not improve. The result was not statistically significant. Some secondary signals looked promising at six months but faded by twelve months.
September 2, 2026
No Comments
